跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ART-44
首页
药物
ART-44
ART-44
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Mutant protein S27K with 27th serine mutation of streptavidin and application of mutant protein S27K
CN 117264035 A
申请人: UNIV SOUTHWEST
优先权: 2022
CN
4 件公开
External medicine for onychomycosis
CN 101229188 B
申请人: WEIJUN LANG
优先权: 2008
CN
METHODS AND COMPOSITIONS FOR TARGETED IMAGING
WO 2011044545 A3
申请人: SIGALOV ALEXANDER B
优先权: 2009
WO
Myrrh traditional Chinese medicinal preparation
CN 103536675 A
申请人: YUAN HUI
优先权: 2013
CN
BB cushion cream with light-induction color adjustment, light weight and blemish covering effects
CN 104546651 A
申请人: GUANGZHOU JIUMEI QIANHUI BIOLOG TECHNOLOGY CO LTD
优先权: 2014
CN
Preparation method of rhizoma gastrodiae liquor
CN 106880803 A
申请人: GUIZHOU LEISHAN MIAOREN PRIMITIVE EXPL CO LTD
优先权: 2015
CN
Traditional Chinese medicine composition for treating liver cirrhosis and preparation method thereof
CN 105663509 A
申请人: ZHENG YINGLAN
优先权: 2016
CN
Making method of snake wine
CN 106109720 A
申请人: SANJIANG COUNTY LIANXING SNAKE IND CO LTD
优先权: 2016
CN
Medicinal composition for treating chronic gastritis
CN 107773655 A
申请人: ZHOU LI
优先权: 2016
CN
SOLID PHARMACEUTICAL ORAL DOSAGE FORM COMPRISING AN EXTENDED RELEASE OF THE ACTIVE INGREDIENT COMPRISING MIRABEGRON
EP 3335700 A1
申请人: STADA ARZNEIMITTEL AG
优先权: 2016
EP
第 1 / 2 页
上一页
下一页
药物
反馈